Edwards Lifesciences Corporation (EW) delivered a return of 18.09% over the past year. Since EW does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Edwards Lifesciences Corporation one year ago would be worth $11,809 today, representing a gain of $1,809.

Edwards Lifesciences Corporation (EW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For EW, the total return equals the price-only return.

No, Edwards Lifesciences Corporation (EW) underperformed the S&P 500 by 6.90 percentage points over the past year. EW delivered a total return of 18.09%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed EW by 6.90pp during this period.

Edwards Lifesciences Corporation (EW) experienced a maximum drawdown of -12.73% over the past year, declining from its peak on 2025-12-29 to its trough on 2026-02-13. The stock recovered to its prior peak by 2026-03-02. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Edwards Lifesciences Corporation (EW)'s long-term returns with dividends reinvested. Over 10 years, the total return is 164.3% (10.2% CAGR) — $10,000 would have grown to $26,430. Over 20 years: 2229.0% total return (17.0% CAGR) — $10,000 → $232,904. Over 30 years: 6253.5% total return (14.8% CAGR) — $10,000 → $635,347. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Edwards Lifesciences Corporation's best calendar year was 2014 with a total return of 93.2%. Its worst year was 2022 with a total return of -41.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 135.1 percentage points.